Extending the dosing interval of COVID-19 vaccination leads to higher rates of seroconversion in people living with HIV.
Frontiers in immunology（2023）
Abstract
https://beta.clinicaltrials.gov/study/NCT05075070, identifier NCT05075070.
MoreTranslated text
Key words
dosing interval,inactivated COVID-19 vaccination,neutralizing antibody,people living with HIV,seroconversion
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined